ArticleEuropean journal of pharmacology2025
Deep learning-driven proteomics analysis for gene annotation in the renin-angiotensin system.
Article in European journal of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Machine learning models for predicting cerebrospinal fluid bacterial culture outcomes in post-neurosurgical meningitis-development and temporal three-year validation.Archives of microbiology · 2026Article
- Sex-Specific Exosome Cargo Reveals Potential New Mechanisms of Salt-Sensitive Hypertension.Hypertension (Dallas, Tex. : 1979) · 2026Article
- AGTR1 inhibits pyroptosis and inflammatory cytokine secretion in rheumatoid arthritis fibroblast-like synoviocytes through the TGF-β pathway.American journal of translational research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
The renin-angiotensin system (RAS) is central to cardiovascular diseases such as hypertension and cardiomyopathy, yet the functions of many RAS genes remain unclear. This study developed a multi-label deep learning model to systematically annotate RAS gene functions and elucidate their roles in biological pathways. A total of 39,463 RAS-related publications from PubMed and PMC were processed into text format. Feature matrices were generated using TF-IDF and token processing, followed by dimensionality reduction via Principal Component Analysis (PCA). A Multi-Layer Perceptron (MLP) was applied for multi-label classification, with performance evaluated using Precision, F1-Score, Ranking Loss, and ROC-AUC metrics. The model outperformed traditional methods (SVM, Random Forest), achieving a Precision of 0.7474 and ROC-AUC of 0.8697. Grouping into three major biological branches improved interpretability and performance (Precision: 0.8312; ROC-AUC: 0.9182). In silico predictions were validated using extracellular vesicle (EV) proteomics and capillary Western assays in DOCA-salt hypertensive mice. Key genes-AGTR2, IRAP (LNPEP), Ywhas (SFN), EDNRA, and ESR2-were identified as critical RAS components. Notably, IRAP was markedly upregulated in hypertension and showed regulatory interactions with 14-3-3 proteins, modulating Nedd4-2, ACE2, and AGTR1 signaling. To our knowledge, this is the first integration of multi-label AI modeling with EV proteomics for RAS pathway annotation. This framework captures complex gene-pathway relationships, advancing systems-level understanding of RAS biology and revealing a novel IRAP/Ywha(s)/Nedd4-2-ACE2 interaction axis as a potential therapeutic target.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.